Methotrexate and epirubicin conjugates as potential antitumor drugs
Journal Title: Advances in Hygiene and Experimental Medicine - Year 2017, Vol 71, Issue
Abstract
Introduction: The use of hybrid molecules has become one of the most significant approaches in new cytotoxic drug design. This study describes synthesis and characterization of conjugates consisting of two well-known and characterized chemotherapeutic agents: methotrexate (MTX) and epirubicin (EPR). The synthesized conjugates combine two significant anticancer strategies: combinatory therapy and targeted therapy. These two drugs were chosen because they have different mechanisms of action, which can increase the anticancer effect of the obtained conjugates. MTX, which is a folic acid analog, has high cytotoxic properties and can serve as a targeting moiety that can reach folate receptors (FRs) overexpresing tumor cells. Combination of nonselective drugs such as EPR with MTX can increase the selectivity of the obtained conjugates, while maintaining the high cytotoxic properties.Materials and methods: Conjugates were purified by RP-HPLC and the structure was investigated by MS and MS/MS methods. The effect of the conjugates on proliferation of LoVo, LoVo/Dx, MCF-7 and MV-4-11 human cancer cell lines was determined by SRB or MTT assay.Results: The conjugation reaction results in the formation of monosubstituted (α, γ) and disubstituted MTX derivatives. In vitro proliferation data demonstrate that the conjugates synthesized in our study show lower cytotoxic properties than both chemotherapeutics used alone.Discussion: Epirubicin cytotoxicity was not observed in obtained conjugates. Effective drugs release after internalization needs further investigation.
Authors and Affiliations
Szymon Wojciech Kmiecik, Mateusz Adam Krzyścik, Beata Filip-Psurska, Joanna Wietrzyk, Janusz Boratyński, Tomasz Marek Goszczyński
Keywords
Related Articles
- EP ID EP220408
- DOI 10.5604/01.3001.0010.3842
- Views 139
- Downloads 0
Novel PKD1 mutations – the effect on clinical phenotype of ADPKD patients in Lower Silesia
Introduction: Autosomal dominant polycystic kidney disease (ADPKD) is characterized by the development and progressive enlargement of cysts in the kidneys. The diagnosis of ADPKD is usually determined by criteria of rena...
Nowy sposób indukcji hiperemii wieńcowej
Koronarografia i pomiar cząstkowej rezerwy przepływu wieńcowego (FFR) służą do anatomicznej i czynnościowej oceny zwężeń w tętnicach wieńcowych. Prawidłowy pomiar FFR krytycznie zależy od uzyskania maksymalnego przekrwie...
Health-promoting properties of pectin
Pectin, a heteropolysaccharide commercially derived from the cell wall of higher plants, is mainly used in food as a gelling agent in jams and jellies as well as a stabilizer in fruit juice and milk drinks. It has also r...
Wpływ substancji P na komórki krwi
SP jest wydzielana przez włókna nerwowe unerwiające narządy limfatyczne, przez komórki podścieliska szpiku kostnego oraz same komórki hematopoetyczne. Większość obecnych w szpiku kostnym komórek, zarówno hematopoetycznyc...
Uroplakiny jako markery chorób układu moczowego
Unikatowym elementem budowy pęcherza moczowego jest urotelium, wielowarstwowa błona, która rozciąga się od miedniczki nerkowej do cewki moczowej. Błona urotelialna pokrywa w ponad 90% wewnętrzną część pęcherza moczowego...